Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,657 | 300 | 99.6% |
| Education | $21.70 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $547.21 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $543.34 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $472.59 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $447.60 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $427.94 | 21 | $0 (2024) |
| Amgen Inc. | $414.91 | 25 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $355.90 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $334.39 | 24 | $0 (2024) |
| PFIZER INC. | $282.55 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $215.07 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,505 | 63 | AstraZeneca Pharmaceuticals LP ($274.98) |
| 2023 | $1,138 | 59 | E.R. Squibb & Sons, L.L.C. ($275.83) |
| 2022 | $1,283 | 79 | E.R. Squibb & Sons, L.L.C. ($196.76) |
| 2021 | $1,753 | 100 | Janssen Pharmaceuticals, Inc ($309.21) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.80 | General |
| 11/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: DIABETES | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Obesity | ||||||
| 09/02/2024 | Abbott Laboratories | AMPLATZER (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Structural Heart | ||||||
| 08/29/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Not Applicable | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $19.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.63 | General |
| 08/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $28.21 | General |
| Category: Cardiology | ||||||
| 06/24/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Not Applicable | ||||||
| 06/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $76.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 708 | 1,434 | $206,856 | $56,579 |
| 2022 | 8 | 402 | 688 | $102,698 | $30,994 |
| 2021 | 5 | 293 | 395 | $80,431 | $20,342 |
| 2020 | 6 | 331 | 487 | $96,242 | $20,755 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 386 | $98,299 | $28,797 | 29.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 56 | 387 | $45,333 | $11,969 | 26.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 54 | 232 | $22,576 | $7,228 | 32.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 37 | 104 | $8,235 | $2,662 | 32.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 167 | 192 | $16,645 | $1,653 | 9.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,880 | $1,441 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 24 | $4,152 | $1,337 | 32.2% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 21 | 21 | $3,927 | $807.87 | 20.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 46 | 54 | $1,134 | $453.60 | 40.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 19 | 19 | $675.26 | $229.71 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 262 | $67,096 | $21,135 | 31.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 34 | 106 | $12,417 | $3,583 | 28.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 32 | 87 | $8,466 | $2,747 | 32.4% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 25 | 67 | $5,305 | $1,774 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $2,422 | $772.28 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 47 | 52 | $4,470 | $447.00 | 10.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 29 | 29 | $1,031 | $332.01 | 32.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 53 | 71 | $1,491 | $204.33 | 13.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 238 | $67,594 | $17,845 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 23 | $4,324 | $1,341 | 31.0% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 17 | 30 | $2,750 | $536.12 | 19.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 73 | 81 | $4,212 | $400.44 | 9.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 21 | 23 | $1,551 | $219.48 | 14.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 166 | 280 | $79,240 | $17,732 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 31 | $5,828 | $1,350 | 23.2% |
About Twilla Walker, FNP
Twilla Walker, FNP is a Family healthcare provider based in Statesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1770756512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Twilla Walker, FNP has received a total of $5,679 in payments from pharmaceutical and medical device companies, with $1,505 received in 2024. These payments were reported across 301 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,657).
As a Medicare-enrolled provider, Walker has provided services to 1,734 Medicare beneficiaries, totaling 3,004 services with total Medicare billing of $128,669. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Statesville, NC
- Active Since 04/11/2008
- Last Updated 11/03/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1770756512
Products in Payments
- XARELTO (Drug) $547.21
- JARDIANCE (Drug) $543.34
- Repatha (Biological) $414.91
- CAMZYOS (Drug) $340.97
- VERQUVO (Drug) $334.39
- ELIQUIS (Drug) $314.42
- ENTRESTO (Drug) $257.78
- UPTRAVI (Drug) $221.45
- Kerendia (Drug) $196.62
- MULTAQ (Drug) $194.74
- FARXIGA (Drug) $191.22
- FUROSCIX (Drug) $188.81
- LEQVIO (Drug) $170.16
- Arcalyst (Drug) $156.49
- OPSUMIT (Drug) $134.45
- Vascepa (Drug) $118.51
- CARDIOMEMS (Device) $109.97
- Impella (Device) $104.06
- Ozempic (Drug) $96.34
- LOKELMA (Drug) $76.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Statesville
Kimberly Woods, Fnp-C, FNP-C
Family — Payments: $29,095
Deborah Daywalt, Fnp, FNP
Family — Payments: $9,509
Mrs. Theresa Williams, Fnp-C, FNP-C
Family — Payments: $7,686
Kristen Pawlowski, Aprn, APRN
Family — Payments: $7,263
Mrs. Elizabeth Lowrance, Fnp-C, FNP-C
Family — Payments: $7,232
April Lockman, Fnp, FNP
Family — Payments: $6,777